Federal Register / Vol. 77, No. 43 / Monday, March 5, 2012 / Notices 13131 

Estimated Total Annual Burden 

Hours: 6,292. 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information may be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. Email address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection activity— 

National Child Abuse and Neglect Data 

System. 

The Department specifically requests 

comments on: (a) The proposed change 

to the two data collection instruments— 

the Child File and the Agency File; (b) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(c) the quality, utility, and clarity of the 

information to be collected; (d) the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information; and (e) ways to minimize 

the burden of the collection of 

information on respondents, including 

through the use of automated collection 

techniques or other forms of information 

technology. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2012–5251 Filed 3–2–12; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2012–N–0001] 

Advisory Committees; Filing of Closed 

Meeting Reports 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that, as required by the Federal 

Advisory Committee Act, the Agency 

has filed with the Library of Congress 

the annual reports of those FDA 

advisory committees that held closed 

meetings during fiscal year 2011. 

ADDRESSES: Copies are available from 

the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852, 301–827– 

6860. 

FOR FURTHER INFORMATION CONTACT: 

Teresa L. Hays, Advisory Committee 

and Oversight Management Staff, Food 

and Drug Administration, 10903 New 

Hampshire Ave., Silver Spring, MD 

20993, 301–796–8220. 

SUPPLEMENTARY INFORMATION: Under 

section 10(d) of the Federal Advisory 

Committee Act (5 U.S.C. app.) and 21 

CFR 14.60(d), FDA has filed with the 

Library of Congress the annual reports 

for the following FDA advisory 

committees that held closed meetings 

during the period October 1, 2010 

through September 30, 2011: 

Center for Biologics Evaluation and 

Research 

Allergenic Products Advisory 

Committee 

Blood Products Advisory Committee 

Cellular, Tissue and Gene Therapies 

Advisory Committee 

Vaccines and Related Biological 

Products Advisory Committee 

Center for Drug Evaluation and 

Research 

Cardiovascular and Renal Drugs 

Advisory Committee 

Gastrointestinal Drug Advisory 

Committee 

National Center for Toxicological 

Research 

Science Board to the National Center for 

Toxicological Research 

Center for Tobacco Products 

Tobacco Products Scientific Advisory 

Committee 

Annual reports are available for 

public inspections between 9 a.m. and 

4 p.m., Monday through Friday. 

• The Library of Congress, Madison 

Bldg., Newspaper and Current 

Periodical Reading Room, 101 

Independence Ave. SE., Rm. 133, 

Washington, DC; and 

• The Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

Dated: February 23, 2012. 

Jill Hartzler Warner, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2012–5208 Filed 3–2–12; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection: Comment 

Request Post-Award Reporting 

Requirements Including New Research 

Performance Progress Report 

Collection 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

Office of the Director, National 

Institutes of Health (NIH) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: Public 

Health Service (PHS) Post-award 

Reporting Requirements. Type of 

Information Collection Request: 

Revision. This collection represents a 

consolidation of post-award reporting 

requirements under the PRA, and 

includes the new Research Performance 

Progress Report (RPPR). Need and Use 

of Information Collection: The RPPR 

will replace existing interim 

performance reports used by all NIH, 

Food and Drug Administration, Centers 

for Disease Control and Prevention, and 

Agency for Healthcare Research and 

Quality (AHRQ) grantees. Interim 

progress reports are required to continue 

support of a PHS grant for each budget 

year within a competitive segment. The 

phased transition to the RPPR requires 

the maintenance of dual reporting 

processes for a period of time. Thus this 

information collection is for the new use 

of the RPPR, and continued use of the 

PHS Non-competing Continuation 

Progress Report (PHS 2590, currently 

approved under 0925–0001), and the 

NIH AHRQ Ruth L. Kirschstein National 

Research Service Award (NRSA) 

Individual Fellowship Progress Report 

for Continuation Support (PHS 416–9, 

currently approved under 0925–0002). 

Only one interim progress report (RPPR 

or PHS2590/416–9) will be utilized for 

any given award. This collection also 

includes other PHS post-award 

reporting requirements: PHS 416–7 

NRSA Termination Notice, PHS 2271 

Statement of Appointment, 6031–1 

NRSA Annual Payback Activities 

Certification, (currently approved under 

0925–0002, expiration 6/30/2012); and 

HHS 568 Final Invention Statement and 

Certification, Final Progress Report 

instructions, and iEdison, and PHS 3734 

Statement Relinquishing Interests and 

Rights in a PHS Research Grant 


erowe on DSK2VPTVN1PROD with NOTICES